logo

Immunogen Inc (IMGN)



Trade IMGN now with
  Date
  Headline
2/8/2019 6:37:00 AM ImmunoGen FY Net Loss Of $167.9 Mln Or $1.20/Shr Vs Loss Of $96.0 Mln Or $0.98/Shr Last Year
11/26/2018 4:02:51 PM ImmunoGen Announces Resignation Of David Johnston As CFO
11/2/2018 6:34:05 AM ImmunoGen Q3 Net Loss $46.8 Mln Or $0.32/Shr Vs Net Loss $56.7 Mn Or $0.61/Shr Prior Year
10/22/2018 7:20:53 AM William Blair Reiterates Immunogen Inc (IMGN) At Outperform
10/20/2018 6:37:59 AM ImmunoGen Presents Initial Data From FORWARD II Expansion Cohort Assessing Mirvetuximab Soravtansine With KEYTRUDA
7/27/2018 6:35:41 AM ImmunoGen Q2 Net Loss Widens To $41.6 Mln Or $0.31/shr From $8.9 Mln Or $0.10/shr Last Year
6/6/2018 9:04:59 PM ImmunoGen Announces Pricing Of An Upsized Underwritten Public Offering Of 13.70 Mln Shares At $11.00/shr
6/5/2018 4:04:39 PM ImmunoGen Announces Proposed Public Offering Of Common Stock
5/4/2018 6:35:37 AM ImmunoGen Q1 Net Loss $38.6 Mln Or $0.30/Shr Vs Net Loss $17.3 Mln Or $0.20/Shr Last Year
4/25/2018 8:04:47 AM ImmunoGen Names Blaine McKee EVP And Chief Business Officer
2/9/2018 6:32:32 AM ImmunoGen FY Revenues $115.4 Mln Vs $48.6 Mln Last Year
1/24/2018 8:09:59 AM ImmunoGen Appoints Stuart Arbuckle To Board